Michael Paris

Michael Paris serves as Chief Executive Officer at Menarini Silicon Biosystems. Menarini Silicon Biosystems operates in the biotechnology sector with approximately 180.0 employees. The company is headquartered in Bridgewater, New Jersey. Menarini Silicon Biosystems generates annual revenue of 35000000.0. To date, Menarini Silicon Biosystems has raised 6830000.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • We have verified contacts for 2 executives at Menarini Silicon Biosystems.
• • 1,484 executive contacts are available in New Jersey.
• • Our database includes 201,469 c suite-level executives.

Gmail Google Apps Microsoft Office 365 OneTrust Pardot Vimeo Bootstrap Framework Adobe Media Optimizer YouTube Google Maps AngularJS Mobile Friendly reCAPTCHA Citrix NetScaler Cedexis Radar DotNetNuke Google Maps (Non Paid Users) Google Tag Manager Google Font API TikTok Remote AI

cell sorting circulating tumor cells single cell analysis resolving tumor heterogeneity rare cell isolation forensics cellsearch ctc liquid biopsy circulating cell cancer lab services biopharma multiple myeloma breast cancer ctc enumeration clinical trial genomic profiling lowpass sequencing cancer panel molecual analysis deparray cell enrichment cell enumeration molecular characterization oncology diagnostics rare cell detection non-invasive testing clinical research biopharma partnership fda-cleared tests laboratory-developed tests molecular profiling cancer biomarker multicellular analysis immunomagnetic capture quality control circulating endothelial cells circulating multiple myeloma cells blood cancer diagnostics cell-based prenatal testing deparray technology fully automated systems cellular heterogeneity tumor monitoring healthcare analytics patient management therapeutic strategies clinical trials custom research lab services forensic applications biomedical research sample preparation kits next-generation sequencing library preparation metastatic cancer diagnostic aid liquid biopsy platform tissue biopsy sorting cellfind technology ctc count cellmag consumables staining protocols high throughput actionable insights precision medicine oncology ctc detection non-invasive prenatal testing rare cell analysis single-cell precision clinical oncology biopharma services drug discovery personalized patient care cancer diagnostics advanced diagnostics cell capture cellsearch system tumor heterogeneity biomarker discovery healthcare innovation patient-centered care molecular pathology genetic profiling therapeutic development research institutions cancer research healthcare providers global presence diagnostic solutions health care health wellness & fitness hospital & health care

RS

Ralf Schoenbrunner Chief Mountain Officer at Menarini Silicon Biosystems

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

How can I contact Michael Paris?

Michael Paris's verified email address is available on MessageCEO. They currently work at Menarini Silicon Biosystems. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Michael Paris lead?

Michael Paris is Chief Executive Officer at Menarini Silicon Biosystems, a company in the biotechnology sector with 180.0 employees. The company is based in Bridgewater, New Jersey.

What industry is Michael Paris in?

Michael Paris works in the biotechnology industry as Chief Executive Officer at Menarini Silicon Biosystems. MessageCEO provides verified contact information for executives across all major industries.

Is Michael Paris's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Michael Paris's profile is kept up-to-date with the latest available information.

Last updated: April 17, 2026